Patents by Inventor Travis Hughes

Travis Hughes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240239610
    Abstract: A harvesting system may include a harvester apparatus defining an onboard storage structure and having a primary movement direction, and including a harvesting head and a crop material conveying structure for conveying the crop materials from the storage structure to a crop transporting vehicle. The conveying structure may have an auger assembly with an inboard end and an outboard end, and a dispensing spout at the outboard end. The auger assembly may include an inboard portion located toward the inboard end and an outboard portion located toward the outboard end, the outboard portion being movable with respect to the inboard portion. The outboard portion may be movable with respect to the inboard portion between a base position and a discharge position, and interiors of the inboard and outboard portions may be in communication with each other in at least the base and discharge positions of the outboard portion.
    Type: Application
    Filed: January 13, 2023
    Publication date: July 18, 2024
    Inventors: TRAVIS HUGHES, BRANDON ALBERTS
  • Patent number: 11865168
    Abstract: Provided herein are compositions and methods for therapeutic and/or prophylactic treatment of an intracellular bacterial infection in a subject in need thereof, comprising one or more modulating agents, wherein the one or more modulating agents increase expression of IFN?, IL-2, TNF, and/or IL-17 in systemic and/or lung T cells. In some embodiments, the increase of expression of IFN?, IL-2, TNF, and/or IL-17 occurs in lung T cells. The lung T cells can be lung resident T cells or systemic T cells that are recruited to the lung. In some embodiments, the T cells are CD4+ and/or CD8+ T cells. In some embodiments, the intracellular bacterial infection is a Mycobacterium tuberculosis (MTB) infection.
    Type: Grant
    Filed: December 30, 2020
    Date of Patent: January 9, 2024
    Assignees: Massachusetts Institute of Technology, The United States of America, as represented by The Secretary, Department of Health & Human Services, University of Pittsburgh—Of The Commonwealth System of Higher Education
    Inventors: Alexander K. Shalek, Travis Hughes, Marc H. Wadsworth, Robert Seder, Mario Roederer, Joanne L. Flynn, Patricia Darrah
  • Publication number: 20230348899
    Abstract: The present invention relates to methods of detecting region(s) of interest in a gene comprising a polyA tail. The region(s) of interest can include gene(s), region(s), mutation(s), deletion(s), insertion(s), indel(s), and/or translocation(s). The region(s) can be greater than or less than 1 kilobases from the polyA tail. Methods can include forming a library of single cell transcripts comprising the region(s) in close proximity to a cell barcode and a unique molecular identifier (UMI). Methods for distinguishing cells by genotype can include amplifying the transcripts using PCR methods and detecting the cell barcode and UMI using single cell sequencing methods. Transcripts can be enriched using tagged region-specific PCR primers. Cell barcodes can be brought into close proximity to the region(s) by circularizing the transcripts. Sequencing of the transcripts can include using primer binding sites added during PCR amplification and library indexes for multiplexed sequencing.
    Type: Application
    Filed: June 13, 2023
    Publication date: November 2, 2023
    Inventors: Peter van Galen, Volker Hovestadt, Travis Hughes, Marc H. Wadsworth II, Bradley Bernstein, Alexander K. Shalek, Todd M. Gierahn, J. Christopher Love, Ang A. Tu
  • Patent number: 11732257
    Abstract: The present invention relates to methods of detecting region(s) of interest in a gene comprising a polyA tail. The region(s) of interest can include gene(s), region(s), mutation(s), deletion(s), insertion(s), indel(s), and/or translocation(s). The region(s) can be greater than or less than 1 kilobases from the polyA tail. Methods can include forming a library of single cell transcripts comprising the region(s) in close proximity to a cell barcode and a unique molecular identifier (UMI). Methods for distinguishing cells by genotype can include amplifying the transcripts using PCR methods and detecting the cell barcode and UMI using single cell sequencing methods. Transcripts can be enriched using tagged region-specific PCR primers. Cell barcodes can be brought into close proximity to the region(s) by circularizing the transcripts. Sequencing of the transcripts can include using primer binding sites added during PCR amplification and library indexes for multiplexed sequencing.
    Type: Grant
    Filed: October 23, 2018
    Date of Patent: August 22, 2023
    Assignees: Massachusetts Institute of Technology, The General Hospital Corporation
    Inventors: Peter van Galen, Volker Hovestadt, Travis Hughes, Marc H. Wadsworth, II, Bradley Bernstein, Alexander K. Shalek, Todd M. Gierahn, J. Christopher Love, Ang A. Tu
  • Publication number: 20220067607
    Abstract: Disclosed herein are various embodiments for a cloud resources allocation system. An embodiment operates by determining that an application requests a plurality of instances to execute across one or more processors of a cloud services platform. One or more spare instances are requested to fulfill at least a portion of the plurality of instances, and an allocation of at least a subset of the requested one or more spare instances is received. An execution of the application is directed to the allocated subset of the one or more spare instances, including a first spare instance. A notification is received from the cloud services platform that the first spare instance is to be reallocated to a different process. A subsequent execution of the application is redirected to an on demand instance of the cloud services platform.
    Type: Application
    Filed: August 26, 2020
    Publication date: March 3, 2022
    Applicant: Capital One Services, LLC
    Inventors: ASHISH KUMAR, Kishan PATEL, Travis HUGHES, Mathew VERGHESE, Saugata MONDAL, Pradeep KHANDELWAL
  • Publication number: 20210213126
    Abstract: Provided herein are compositions and methods for therapeutic and/or prophylactic treatment of an intracellular bacterial infection in a subject in need thereof, comprising one or more modulating agents, wherein the one or more modulating agents increase expression of IFN?, IL-2, TNF, and/or IL-17 in systemic and/or lung T cells. In some embodiments, the increase of expression of IFN?, IL-2, TNF, and/or IL-17 occurs in lung T cells. The lung T cells can be lung resident T cells or systemic T cells that are recruited to the lung. In some embodiments, the T cells are CD4+ and/or CD8+ T cells. In some embodiments, the intracellular bacterial infection is a Mycobacterium tuberculosis (MTB) infection.
    Type: Application
    Filed: December 30, 2020
    Publication date: July 15, 2021
    Inventors: Alexander K. Shalek, Travis Hughes, Marc H. Wadsworth, Robert Seder, Mario Roederer, Joanne L. Flynn, Patricia Darrah
  • Publication number: 20200248175
    Abstract: The present invention relates to methods of deriving genetic information from RNA-seq libraries, that can enable an overlay of genetic information (such as cancer driver mutations) onto single-cell transcriptomes and permitting efficient identification, localization, and quantification of certain cells of interest within a population as well as provide low-cost selection and sequencing of any portion of a transcript, including at the 5? end.
    Type: Application
    Filed: October 23, 2018
    Publication date: August 6, 2020
    Inventors: Peter van Galen, Volker Hovestadt, Travis Hughes, Marc H. Wadsworth II, Bradley Bernstein, Alexander K. Shalek, Todd M. Gierahn, J. Christopher Love, Ang A. Tu
  • Publication number: 20130337556
    Abstract: Methods of delivering transgenes to target cells using plasmids comprising viral inverted terminal repeat (ITR) sequences are described. Such plasmids are capable of directing sustained transgene expression in target cells in rats provided that at least one adeno-associated virus (AAV) ITR sequence is present in the plasmid, regardless of whether that ITR is located upstream or downstream of the transgene. In a particular embodiment, plasmids comprising one or more AAV ITR sequence and an IL-10 transgene are shown to be effective in sustained reversal of pain in an animal model of neuropathic pain.
    Type: Application
    Filed: July 23, 2013
    Publication date: December 19, 2013
    Applicant: The Regents of the University of Colorado, a body corporate
    Inventors: Linda Watkins, Travis Hughes, Raymond Chavez
  • Patent number: 8524678
    Abstract: Methods of delivering transgenes to target cells using plasmids comprising viral inverted terminal repeat (ITR) sequences are described. Such plasmids are capable of directing sustained transgene expression in target cells in rats provided that at least one adeno-associated virus (AAV) ITR sequence is present in the plasmid, regardless of whether that ITR is located upstream or downstream of the transgene. In a particular embodiment, plasmids comprising one or more AAV ITR sequence and an IL-10 transgene are shown to be effective in sustained reversal of pain in an animal model of neuropathic pain.
    Type: Grant
    Filed: May 26, 2006
    Date of Patent: September 3, 2013
    Assignee: The Regents of the University of Colorado, a body corporate
    Inventors: Linda May Rothblum Watkins, Travis Hughes, Raymond A. Chavez
  • Publication number: 20090208563
    Abstract: Methods of delivering transgenes to target cells using plasmids comprising viral inverted terminal repeat (ITR) sequences are described. Such plasmids are capable of directing sustained transgene expression in target cells in rats provided that at least one adeno-associated virus (AAV) ITR sequence is present in the plasmid, regardless of whether that ITR is located upstream or downstream of the transgene. In a particular embodiment, plasmids comprising one or more AAV ITR sequence and an IL-10 transgene are shown to be effective in sustained reversal of pain in an animal model of neuropathic pain.
    Type: Application
    Filed: May 26, 2006
    Publication date: August 20, 2009
    Inventors: Linda May Rothblum Watkins, Travis Hughes, Raymond A. Chavez